Moreover, this carotenoid can reduce N-cadherin, beta-catenin expression, increase expression of E-cadherin, and down-regulate matrix metalloproteinases 2 and 9, and urokinase-type plasminogen activator expression/activity in tumor cells. Here, CTNNB1 is linked to neoplasm.